Best Practice & Research Clinical Rheumatology
Volume 24, Issue 4 , Pages 457-461, August 2010

Challenges in clinical trial design in inflammatory arthritis☆

  • James R. O'Dell, MD (Larson Professor and Vice-Chairman Internal Medicine, Chief of Rheumatology, Residency Program Director)

      Affiliations

    • Corresponding Author InformationTel.: +1 402 559 7288; Fax: +1 402 559 6788.

Department of Internal Medicine, University of Nebraska Medical Center and the Omaha Veteran Administration Hospital, 983025 Nebraska Medical Center, Omaha, Nebraska 68198-3025, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ RA: Trial design crisis in the midst of an abundance of therapeutic options. Or – If we don't change direction soon, we will end up where we are going.

PII: S1521-6942(09)00144-2

doi:10.1016/j.berh.2009.11.008

Best Practice & Research Clinical Rheumatology
Volume 24, Issue 4 , Pages 457-461, August 2010

Article Tools